For HCPs, trust means demonstrating that you understand what it’s like to work under their constraints: time pressure, patient complexity and compliance requirements.
For hospital administrators and procurement leaders, trust means making ROI visible and compliance obvious. If you make that job harder, you create friction that translates into delay or even disqualification.
For patients and caregivers, trust means plain language and genuine empathy. They’re not looking for clinical sophistication; they want reassurance that what you offer was designed with their wellbeing as the primary consideration.
Therefore, trust is not a single message. It’s the cumulative, consistent impression every touchpoint creates: every ad, email, page on your site and piece of content your audience finds before they even meet your team. According to Health Launchpad, 74% of healthcare buyers trust input from industry peers more than any other source, and an HIMSS study reveals that 70% of the buyer’s decision journey occurs before contacting vendors.
Digital isn’t just an awareness play. In MedTech, every channel is a trust-building opportunity when done right.
In Digital Commerce 360, Forrester says that “B2B buying today is a process of confirmation, not selection. Decisive buyers already know who they want to work with before they start gathering requirements or talking to vendors.”
There are five important moves that can meaningfully close the pre-sale trust gap:
Analyze your pre-sale touchpoints carefully. Do it from the standpoint of a skeptical HCP, procurement officer or hospital administrator. What does your website say to someone who has never heard of you? What shows up when they Google your brand name alongside your competitors? What does your LinkedIn content communicate about your depth of expertise? Remember that most buyers start with a vendor already in mind. If you don’t get into that mental shortlist, no amount of great sales conversation will make you win the deal.
Lead with outcomes, not features. Frame… or reframe your web copy, ads, emails, sales collateral around what changes for the provider or the patient. For example: From our device is 40% faster to our device reduces process time, so your team can see more patients without increasing workload. The feature is the proof; the outcome is the story. Research consistently shows content addressing outcomes and success stories ranks among the most influential for B2B healthcare buyers.
Make clinical evidence findable and readable. Invest in making clinical data accessible and digestible—summary pages, visual data presentations, short explainers written for clinical audiences. If your proof is strong, it should do the heavy lifting. Get it out into the buyer’s journey where the more than 70% of HCPs doing pre-sale research can easily find it.
Align marketing and sales messaging. The story a buyer encounters in a programmatic ad, on your website, in a follow-up email and in the first sales deck they receive should feel like one continuous narrative. Gaps and contradictions between these touchpoints, even subtle ones, signal organizational dysfunction and erode confidence. The brands that win “pre-contact favorite” status are those that offer a coherent story everywhere.
Use data to personalize by role, specialty and intent. A hospitalist evaluating an infusion device has fundamentally different information needs than a VP of supply chain evaluating the same device. Intent data and audience intelligence tools allow you to deliver the right message to the right stakeholder at the right time. With a combined 57% of organizations involving more than 5 individuals in purchasing decisions, generic messaging isn’t just inefficient; it’s a trust leak at multiple points simultaneously.
The sales call is a test you’ve already either passed or failed
The MedTech brands that will be successful moving forward are the ones that understand trust is built upstream—in content, in data, in channels, in consistency—and invest accordingly. The stakes are rising. According to 6Sense, in their 2025 B2B Buyer Experience report, 94% of buyers are now using LLMs to conduct and organize their pre-sale research. Though they arrive at the sales call better prepared and with firmer opinions already formed, the shortlist still gets built on brand familiarity and peer trust, not on what AI suggests. The brands that “earn” that first call are already winning before the conversation starts.
Ready to close the trust gap?
At RAB2H, we help MedTech brands build the kind of credibility that makes every business conversation easier. From audience intelligence to omnichannel strategy and ABM execution, we align your marketing to the way healthcare buyers approach the buying process today.
Let’s talk to see what your pre-sale journey looks like.
